A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer
出版年份 2013 全文链接
标题
A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer
作者
关键词
Pancreatic cancer, Chemotherapy, Gemcitabine refractory, S-1, Oxaliplatin
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 72, Issue 5, Pages 985-990
出版商
Springer Nature
发表日期
2013-08-31
DOI
10.1007/s00280-013-2278-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer
- (2012) Naminatsu Takahara et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity
- (2011) K-p Kim et al. BRITISH JOURNAL OF CANCER
- A Prognostic Model to Identify Patients with Advanced Pancreas Adenocarcinoma Who Could Benefit from Second-line Chemotherapy
- (2011) Seung Tae Kim et al. CLINICAL ONCOLOGY
- Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group
- (2011) Uwe Pelzer et al. EUROPEAN JOURNAL OF CANCER
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gemcitabine and Oxaliplatin Combination Chemotherapy for Patients with Refractory Pancreatic Cancer
- (2011) Hiroyuki Isayama et al. ONCOLOGY
- Oxaliplatin, 5-Fluorouracil, and Leucovorin as Second-Line Treatment for Advanced Pancreatic Cancer
- (2010) Anna Novarino et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Impact of S-1 in Patients with Gemcitabine-refractory Pancreatic Cancer in Japan
- (2010) Y. Nakai et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Impact of S-1 on the Survival of Patients With Advanced Pancreatic Cancer
- (2010) Yousuke Nakai et al. PANCREAS
- Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer
- (2009) D. Y. Zang et al. ANNALS OF ONCOLOGY
- Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)
- (2009) W. Koizumi et al. ANNALS OF ONCOLOGY
- A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer
- (2009) C Yoo et al. BRITISH JOURNAL OF CANCER
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer
- (2008) Y Yamada et al. BRITISH JOURNAL OF CANCER
- Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer
- (2008) Henry Q. Xiong et al. CANCER
- A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer
- (2008) Chigusa Morizane et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A review on oxaliplatin-induced peripheral nerve damage
- (2008) Andreas A. Argyriou et al. CANCER TREATMENT REVIEWS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started